Evidence map›Paper›PMID 18270197›Full record

ArticleThe Journal of biological chemistry2008

Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro.

Leonard C Shank, Joshua B Kelley, Daniel Gioeli, Chun-Song Yang, Adam Spencer, Lizabeth A Allison, Bryce M Paschal

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2019
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Leonard C ShankCenter for Cell Signaling, Department of Biochemistry and Molecular Genetics, and Cancer Center, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
Joshua B Kelley
Daniel Gioeli
Chun-Song Yang
Adam Spencer
Lizabeth A Allison
Bryce M Paschal
University of Virginia · USToxicologie, Pharmacologie et Signalisation Cellulaire · FRWilliam & Mary · US

Funding

Role of Androgen Receptor Phosphorylation in Prostate CancerR01CA124706 · NCI · UNIVERSITY OF VIRGINIA · PI GIOELI, DANIEL G · 2008 to 2012
$1.6M
NCI NIH HHS R01 CA124706
6 · The paper itself

Abstract

The androgen receptor undergoes nuclear import in response to ligand, but the mechanism by which it undergoes nuclear export is poorly understood. We developed a permeabilized cell assay to characterize nuclear export of the androgen receptor in LNCaP prostate cancer cells. We found that nuclear export of endogenous androgen receptor can be stimulated by short double-stranded DNA oligonucleotides. This androgen receptor export pathway is dependent on ATP hydrolysis and is enhanced by phosphatase inhibition with okadaic acid. Fluorescence recovery after photobleaching in permeabilized cells, under the conditions that stimulate androgen receptor export, suggested that double-stranded DNA-dependent export does not simply reflect the relief of a nuclear retention mechanism. A radiolabeled androgen was used to show that the androgen receptor remains ligand-bound during translocation through the nuclear pore complex. A specific inhibitor to the DNA-dependent protein kinase, NU7026, inhibits androgen receptor export and phosphorylation. In living cells, NU7026 treatment increases androgen-dependent transcription from endogenous genes that are regulated by androgen receptor. We suggest that DNA-dependent protein kinase phosphorylation of the androgen receptor, or an interacting component, helps target the androgen receptor for export from the nucleus.

Indexed as

Active Transport, Cell NucleusAdenosine TriphosphateCell Line, TumorChromonesDNA-Activated Protein KinaseEnzyme ActivationEnzyme InhibitorsGreen Fluorescent ProteinsHumansHydrolysisIn Vitro TechniquesLigandsModels, BiologicalMorpholinesOligonucleotidesPhosphorylation2-(morpholin-4-yl)benzo(h)chromen-4-oneAdenosine TriphosphateChromonesDNA-Activated Protein KinaseEnzyme InhibitorsGreen Fluorescent ProteinsLigandsMorpholinesOligonucleotidesReceptors, Androgen

Identifiers

PMID18270197
PMCPMC7486792
OpenAlexW2020007030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.